Cadence Pharmaceuticals™

SEC Filings

     
 
Filing Description Date Filed Sorted Descending Size
4 garner, cam l Jun 26, 2009 19.9 KB
4 frazier, alan d Jun 26, 2009 20.0 KB
4 berman, michael a Jun 26, 2009 20.1 KB
4 barker, sam l Jun 26, 2009 19.9 KB
4 atwood, brian g Jun 26, 2009 20.0 KB
3 byrd scott a. Jun 25, 2009 21.2 KB
4 craig, william s Jun 25, 2009 20.4 KB
4 blair, james c Jun 25, 2009 19.6 KB
8-K current report Jun 22, 2009 183.8 KB
SC 13G statement of beneficial ownership Jun 10, 2009 20.6 KB
4 berman, michael a May 21, 2009 21.4 KB
4 berman, michael a May 20, 2009 21.2 KB
10-Q quarterly report May 11, 2009 543.1 KB
EFFECT effectiveness order May 7, 2009 0.0 KB
8-K current report May 7, 2009 54.8 KB
DEF 14A definitive proxy statement Apr 29, 2009 477.7 KB
SC 13G/A amended statement of beneficial ownership Apr 10, 2009 27.7 KB
8-K current report Mar 24, 2009 22.7 KB
8-K/A amended current report Mar 23, 2009 22.0 KB
4 breitmeyer, james b Mar 20, 2009 19.8 KB
Showing 41-60 of 269 filings Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14  See Previous 20 | See Next 20
Print page Print
Email page Email


Stock Quote
CADX - (NASDAQ)
$8.70   + 0.03
Nov 20, 2009
4:12 PM ET

Quotes delayed at
least 20 minutes.
Information provided
by eSignal.